Why MenaQ7^® is the Heart Healthy Vitamin

Clinical trials concerning women’s health are few and far between. The Lancet reports that cardiovascular disease among women is under studied, under diagnosed, and under-represented in clinical trials. Although this is concerning, we are proud that our MenaQ7^® is clinically proven to support women’s cardiovascular health, and therefore represents a part of the solution. 

Our groundbreaking 3-year study, published in Thrombosis and Haemostasis, showed post-menopausal women taking a daily nutritional dose of 180 mcg of MenaQ7^®, not only inhibited age-related arterial stiffening but also promoted vascular elasticity. 

Most recently, a poster and abstract of the findings from our 1-year follow-up study were presented at the European Society of Cardiology Congress. The authors confirmed that hormonal changes in women affect the vasculature and leaves post-menopausal women at higher risk. The study showed improved K2 status improves arterial stiffness and blood pressure in post-menopausal women.